The biotech boom that began last year has triggered triple-digit gains in some of the market’s best penny stocks.
And some of our top penny stocks in biotech that we recommended last year gained as much as 440%, 231%, and 214%.
Better yet, the biotech sector is expected to keep surging — especially the sector’s best low-priced buys.
Keep in mind, investing in penny stocks isn’t for everyone, as they operate differently than the typical stock.
However, there are plenty of legitimate and lucrative penny stocks,
if you know how to invest. The key is finding the promising ones and
steering clear of the rest. (more)
Please share this article
Friday, January 31, 2014
Outerwall Inc (NASDAQ: OUTR)
Outerwall Inc., through its subsidiaries, provides automated retail
solutions primarily in the United States, Canada, Puerto Rico, Ireland,
and the United Kingdom. Its Redbox segment owns and operates
approximately 43,700 self-service Redbox kiosks in 35,800 locations that
enable consumers to rent or purchase movies and video games, as well as
purchase event tickets. The company’s Coin segment owns and operates
approximately 20,300 self-service coin-counting kiosks in 20,100
locations, which enable consumers to convert their coin to cash, a gift
card, or an E-certificate. Its New Ventures segment focuses on
identifying, evaluating, building, and developing innovative
self-service concepts in the automated retail space, which includes
coffee, refurbished electronics, and photo self-service concepts. The
company’s kiosks are located primarily in supermarkets, drug stores,
mass merchants, financial institutions, convenience stores, and
restaurants. The company was formerly known as Coinstar, Inc. and
changed its name to Outerwall Inc. in June 2013
Please take a look at the 1-year chart of OUTR (Outerwall, Inc.) below with my added notations:
This stock is very simple. OUTR had held a very important level of support at $65 (blue) for the last 3 months, which was also a previous resistance. Regardless of what the market has or has not down over the last few months though, the stock had never broken the $65 level. Well, this past Friday OUTR broke below the $65 support and should be moving overall lower from here.
The Tale of the Tape: OUTR had a key level of support at $65. Now that the stock has broken support, a trader might want to enter a short trade at or near the $65 level with a stop placed above that level. A break back above $65 would negate the forecast for a move lower.
Please share this article
Please take a look at the 1-year chart of OUTR (Outerwall, Inc.) below with my added notations:
This stock is very simple. OUTR had held a very important level of support at $65 (blue) for the last 3 months, which was also a previous resistance. Regardless of what the market has or has not down over the last few months though, the stock had never broken the $65 level. Well, this past Friday OUTR broke below the $65 support and should be moving overall lower from here.
The Tale of the Tape: OUTR had a key level of support at $65. Now that the stock has broken support, a trader might want to enter a short trade at or near the $65 level with a stop placed above that level. A break back above $65 would negate the forecast for a move lower.
Please share this article
McAlvany Weekly Commentary
Bank to Depositor: It’s Not Your Money!
Posted on 29 January 2014.
About this week’s show:
-Bernanke to Yellen:”Good night and good luck”
-Emerging Market Chaos
-Currency Crises: Replay 2008?
Please share this article
Chart of the Day - Illumina (ILMN)
The Chart of the Day is Illumina (ILMN). I found the stock by sorting the All Time High list for
frequency in the last month then used the Flipchart feature to find the
best chart. Since the Trend Spotter signaled a buy on 10/22 the stock
soared 62.88%.
ILMN is a developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.
Please share this article
ILMN is a developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.
Please share this article
3 Income Plays for Mexico’s Energy Boom: Diamond Offshore Drilling (NYSE: DO), Chesapeake Energy (NYSE: CHK), Energy Transfer Partners LP (NYSE: ETP)
Last week in Income & Prosperity, I presented a thesis for investing in Mexico’s energy market.
My thesis was predicated on the fact you CAN invest in Mexico’s energy market, which for 75 years was closed to foreigners.
Details regarding the Mexican energy reform still need to be hashed out, such as which regions will be available for development and how the contract and licensing procedures will work.
Nevertheless, it’s possible to intelligently game where foreign business will first arise and which U.S. energy companies stand to benefit. (more)
Please share this article
My thesis was predicated on the fact you CAN invest in Mexico’s energy market, which for 75 years was closed to foreigners.
Details regarding the Mexican energy reform still need to be hashed out, such as which regions will be available for development and how the contract and licensing procedures will work.
Nevertheless, it’s possible to intelligently game where foreign business will first arise and which U.S. energy companies stand to benefit. (more)
Please share this article
Subscribe to:
Posts (Atom)